Lifecore Biomedical, Inc. De (LFCR) Revenue (2010 - 2025)

Lifecore Biomedical has reported Revenue for 16 years, with the latest figure at $71.6 million in Q2 2025.

• On a quarterly basis, Revenue rose 88.98% year-over-year to $71.6 million in Q2 2025; TTM through May 2025 was $164.0 million, a 27.88% increase from a year earlier, with the FY2025 full-year figure at $128.9 million, changed 0.47% from the prior year.
• Revenue was $71.6 million for Q2 2025 at Lifecore Biomedical, up from $35.2 million in the prior quarter.
• The five-year high for Revenue was $71.6 million in Q2 2025, with the low at $21.9 million in Q4 2022.
• Average Revenue over 5 years is $32.2 million, with a median of $29.1 million recorded in 2022.
• The sharpest annual moves came in 2021 and 2025: Revenue slumped 81.82% in 2021, then soared 88.98% in 2025.
• Over 5 years, Revenue stood at $25.6 million in 2021, then fell by 14.6% to $21.9 million in 2022, then soared by 37.9% to $30.2 million in 2023, then increased by 8.01% to $32.6 million in 2024, then jumped by 119.87% to $71.6 million in 2025.
• The last three Revenue figures came in at $71.6 million (Q2 2025), $35.2 million (Q1 2025), and $32.6 million (Q4 2024), per Business Quant data.